T. Rowe Price Associates »

Tourmaline Bio shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Tourmaline Bio (TRML) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Tourmaline Bio

Tip: Access up to 7 years of quarterly data

All positions including Tourmaline Bio held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tourmaline Bio by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2024-09-30 $200k 7.8k 25.80

More positions owned by T. Rowe Price Associates

Microsoft Corp Comm Stk (MSFT)
Apple Comm Stk (AAPL)
Nvidia Corporation Comm Stk (NVDA)
Amazon Comm Stk (AMZN)
Meta Platforms Comm Stk (META)
Eli Lilly & Co Comm Stk (LLY)
Alphabet Comm Stk (GOOGL)
Unitedhealth Group Comm Stk (UNH)
Alphabet Comm Stk (GOOG)
Visa Comm Stk (V)
Mastercard Incorporated Comm Stk (MA)
Netflix Comm Stk (NFLX)
Tesla Comm Stk (TSLA)
Intuitive Surgical Comm Stk (ISRG)
Thermo Fisher Scientific Comm Stk (TMO)

View all positions for T. Rowe Price Associates

Top funds holding Tourmaline Bio

RA Capital Management
BlackRock
BlackRock
Blue Owl Capital Holdings
TCG Crossover Management
Jennison Associates
Vanguard Group
Qiming U.S. Ventures Management
QVT Financial
Nantahala Capital Management
Geode Capital Management
Citadel Advisors
Point72 Asset Management
State Street Corporation
Morgan Stanley

View all funds holding Tourmaline Bio